Drugs.com verzenio fda approval history?

I can help with that, but I can’t directly pull up Drugs.com content in real time from here. If you paste the relevant “FDA Approval History” section (or a link/text), I’ll summarize it accurately.

In the meantime, here’s the general FDA approval timeline for Verzenio (abemaciclib) that Drugs.com typically reflects (by label/indication and major approval dates):

Verzenio (abemaciclib) — key FDA approvals (high level)

• 2017: FDA approval for HR+/HER2− advanced or metastatic breast cancer, generally in combination with an endocrine therapy (and/or with fulvestrant depending on the specific label at the time).
• 2018: Additional approvals/label expansions, including for combinations with fulvestrant and/or after prior endocrine-based therapy depending on the regimen.
• 2020: Approval for early breast cancer settings—most notably adjuvant treatment in certain HR+/HER2− node-positive, high-risk patients with Ki-67 ≥ 20% (based on clinical trial results).
• 2021–2022: Further label expansions for early breast cancer and for combinations in metastatic disease depending on prior therapy history and disease risk.
• 2023–2024: Additional indication or regimen updates may have occurred (for example, by specific prior-treatment categories, partner endocrine therapy, or refinements to eligible patient groups).

If you want the exact “Drugs.com FDA approval history” entries

Please do one of these:

1. Paste the Drugs.com “FDA Approval History” text/table here, or
2. Send the Drugs.com URL, and copy the approval-history portion.

Then I’ll produce a clean, date-by-date summary of every FDA approval entry (including the specific indication, label status, and any notes shown on Drugs.com).